- Investing Ideas
- Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Canadian Pharmaceuticals & Biotech Healthy potentially undervalued
Results
8
Companies which are potentially undervalued and in an acceptable financial position.
8 companies
High Tide
Market Cap: CA$297.1m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.27
7D
2.8%
1Y
3.5%
Verano Holdings
Market Cap: CA$572.0m
Engages in the cannabis business in the United States.
VRNO
CA$1.57
7D
-4.8%
1Y
78.4%
Aurora Cannabis
Market Cap: CA$300.4m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$4.88
7D
-0.2%
1Y
-17.3%
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$9.70
7D
4.1%
1Y
29.9%
Decibel Cannabis
Market Cap: CA$75.0m
An integrated cannabis company, engages in the cannabis cultivation in Canada.
DB
CA$0.13
7D
8.3%
1Y
100.0%
Cresco Labs
Market Cap: CA$632.6m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.28
7D
-0.8%
1Y
40.7%
Medexus Pharmaceuticals
Market Cap: CA$127.5m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$3.90
7D
-3.9%
1Y
51.8%
Trulieve Cannabis
Market Cap: CA$1.9b
Operates as a cannabis retailer in the United States.
TRUL
CA$9.54
7D
7.1%
1Y
76.7%